FCGR3A and rheumatoid arthritis: The expansion of CD14+CD16+ monocytes has been reported in a variety of inflammatory disorders including rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) (11, 12, 31), implying an important role of these cells in disease pathogenesis.